Details of the Drug

General Information of Drug (ID: DMYUNXP)

Drug Name
AZD2811
Indication
Disease Entry ICD 11 Status REF
Small-cell lung cancer 2C25.Y Phase 2 [1]
Drug Type
Small molecular drug
Cross-matching ID
TTD ID
DXD69J

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aurora kinase (AURK) TTCY4SB NOUNIPROTAC Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03366675) AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]. U.S. National Institutes of Health.
2 Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo. Sci Transl Med. 2016 Feb 10;8(325):325ra17.
3 Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70.